# Axillary Brachial Plexus Block Using 0.25% Bupivacaine Versus Using 0.19%Bupivacaine in Pediatrics

> **NCT05386095** · NA · COMPLETED · sponsor: **Cairo University** · enrollment: 60 (actual)

## Conditions studied

- Acute Postoperative Pain
- Motor Activity

## Interventions

- **PROCEDURE:** 0.25%Bupivacaine Axillary brachial plexus block
- **PROCEDURE:** 0.19% Bupivacaine Axillary brachial plexus block

## Key facts

- **NCT ID:** NCT05386095
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-29
- **Primary completion:** 2022-10-22
- **Final completion:** 2022-11-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05386095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05386095, "Axillary Brachial Plexus Block Using 0.25% Bupivacaine Versus Using 0.19%Bupivacaine in Pediatrics". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05386095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*